Amoy Diagnostics Co Ltd
SZSE:300685

Watchlist Manager
Amoy Diagnostics Co Ltd Logo
Amoy Diagnostics Co Ltd
SZSE:300685
Watchlist
Price: 26.13 CNY -3.51% Market Closed
Market Cap: 10.2B CNY
Have any thoughts about
Amoy Diagnostics Co Ltd?
Write Note

Relative Value

The Relative Value of one Amoy Diagnostics Co Ltd stock under the Base Case scenario is 38.64 CNY. Compared to the current market price of 26.13 CNY, Amoy Diagnostics Co Ltd is Undervalued by 32%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
38.64 CNY
Undervaluation 32%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
76
vs Industry
55
Median 3Y
10.8
Median 5Y
11.5
Industry
8.1
Forward
8.2
vs History
69
vs Industry
6
Median 3Y
39.1
Median 5Y
41.3
Industry
23
Forward
33.2
vs History
73
vs Industry
7
Median 3Y
58.6
Median 5Y
45.3
Industry
23.4
vs History
73
vs Industry
6
Median 3Y
70.8
Median 5Y
62.1
Industry
27.3
vs History
73
vs Industry
20
Median 3Y
6.4
Median 5Y
7.1
Industry
2.6
vs History
76
vs Industry
50
Median 3Y
10
Median 5Y
10.7
Industry
8.1
Forward
7.3
vs History
73
vs Industry
45
Median 3Y
12.1
Median 5Y
12.8
Industry
9.6
vs History
79
vs Industry
5
Median 3Y
45.3
Median 5Y
42.8
Industry
4.3
Forward
24.6
vs History
79
vs Industry
5
Median 3Y
45.3
Median 5Y
42.8
Industry
3.8
Forward
27.8
vs History
73
vs Industry
8
Median 3Y
54.6
Median 5Y
43.3
Industry
6
vs History
76
vs Industry
6
Median 3Y
95.6
Median 5Y
65.8
Industry
3.8
vs History
57
vs Industry
25
Median 3Y
10.6
Median 5Y
11.3
Industry
4.8

Multiples Across Competitors

Competitors Multiples
Amoy Diagnostics Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
Amoy Diagnostics Co Ltd
SZSE:300685
10.4B CNY 9.2 37.4 31.2 31.2
FR
Pharnext SCA
OTC:PNEXF
6T USD 37 563 478.2 -178 533.6 -216 796.7 -214 322.8
US
Abbvie Inc
NYSE:ABBV
300.2B USD 5.4 59 14.8 22.8
US
Amgen Inc
NASDAQ:AMGN
159.1B USD 4.9 37.4 17.5 33.2
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
126.6B USD 11.9 -263.9 26.7 28
US
Gilead Sciences Inc
NASDAQ:GILD
114.6B USD 4.1 910.1 10.1 10.1
US
Epizyme Inc
F:EPE
94.1B EUR 1 875.5 -478.6 -521.2 -507.3
AU
CSL Ltd
ASX:CSL
137.3B AUD 6 33.7 20.8 25.9
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
87.6B USD 6.3 18.8 17.3 19.2
US
Seagen Inc
F:SGT
39.3B EUR 18.1 -55.4 -59.5 -53.7
NL
argenx SE
XBRU:ARGX
34.1B EUR 18.5 -129.9 -104.5 -76.1
P/E Multiple
Earnings Growth
CN
Amoy Diagnostics Co Ltd
SZSE:300685
Average P/E: 182.7
37.4
81%
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -178 533.6 N/A
US
Abbvie Inc
NYSE:ABBV
59
412%
US
Amgen Inc
NASDAQ:AMGN
37.4
73%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -263.9
42%
US
Gilead Sciences Inc
NASDAQ:GILD
910.1
75%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -478.6 N/A
AU
CSL Ltd
ASX:CSL
33.7
65%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
18.8
43%
US
S
Seagen Inc
F:SGT
Negative Multiple: -55.4 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -129.9 N/A
EV/EBITDA Multiple
EBITDA Growth
CN
Amoy Diagnostics Co Ltd
SZSE:300685
Average EV/EBITDA: 19.8
31.2
81%
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -216 796.7 N/A
US
Abbvie Inc
NYSE:ABBV
14.8
28%
US
Amgen Inc
NASDAQ:AMGN
17.5
63%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
26.7
38%
US
Gilead Sciences Inc
NASDAQ:GILD
10.1
12%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -521.2 N/A
AU
CSL Ltd
ASX:CSL
20.8
42%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.3
46%
US
S
Seagen Inc
F:SGT
Negative Multiple: -59.5 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -104.5 N/A
EV/EBIT Multiple
EBIT Growth
CN
Amoy Diagnostics Co Ltd
SZSE:300685
Average EV/EBIT: 24.3
31.2
75%
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -214 322.8 N/A
US
Abbvie Inc
NYSE:ABBV
22.8
88%
US
Amgen Inc
NASDAQ:AMGN
33.2
93%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
28
44%
US
Gilead Sciences Inc
NASDAQ:GILD
10.1
29%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -507.3 N/A
AU
CSL Ltd
ASX:CSL
25.9
55%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
19.2
54%
US
S
Seagen Inc
F:SGT
Negative Multiple: -53.7 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -76.1 N/A

See Also

Discover More
Back to Top